Varda Space Industries’ Valuable Venture

Varda Space Industries raised $90 million in Series B funding for space-based pharmaceutical manufacturing. Their W-1 capsule successfully produced one gram of a cancer drug in orbit last year. They’ve partnered with biotech giants like Merck, securing $50 million in contracts. A new $30 million deal with a Swiss pharma company supports three additional missions. Their automated reentry capsule reduced costs by 20%, making their business model more attractive to investors.